Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
refer for liver transplantation † Management is the same regardless of hepatitis B e-antigen status. ALT: Alanine transaminase; HBV: Hepatitis B virus; ULN: Upper limit of normal.
However, the X gene itself is encoded within the viral genome ... main challenges with treating hepatitis B is that the existing treatments can stop the virus from making new copies of itself ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...
Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...
refer for liver transplantation † Management is the same regardless of hepatitis B e-antigen status. ALT: Alanine transaminase; HBV: Hepatitis B virus; ULN: Upper limit of normal.